Cargando…
More Haste, Less Speed: Could Public–Private Partnerships Advance Cellular Immunotherapies?
Cellular immunotherapies promise to transform cancer care. However, they must overcome serious challenges, including: (1) the need to identify and characterize novel cancer antigens to expand the range of therapeutic targets; (2) the need to develop strategies to minimize serious adverse events, suc...
Autores principales: | Bubela, Tania, Bonter, Katherine, Lachance, Silvy, Delisle, Jean-Sébastien, Gold, E. Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561330/ https://www.ncbi.nlm.nih.gov/pubmed/28861415 http://dx.doi.org/10.3389/fmed.2017.00134 |
Ejemplares similares
-
Commentary: More haste, less speed
por: Weltert, Luca Paolo, et al.
Publicado: (2020) -
Combining DNA damaging therapeutics with immunotherapy: more haste, less speed
por: Brown, Jessica S, et al.
Publicado: (2018) -
More haste, less speed: Cardiac perforation by a thoracentesis catheter
por: Sueta, Daisuke, et al.
Publicado: (2016) -
Less Haste, More Speed, More Science: Lessons to be Learned from COVID-19 Studies
por: Singer, Mervyn
Publicado: (2022) -
Inflammatory Bowel Disease and the SARS-CoV-2 Pandemic: More Speed, Less Haste
por: Gower-Rousseau, Corinne, et al.
Publicado: (2021)